table of content
1 Introduction to Research & Analysis Reports
1.1 Nuclear Radiopharmaceutical Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Radiopharmaceutical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nuclear Radiopharmaceutical Overall Market Size
2.1 Global Nuclear Radiopharmaceutical Market Size: 2023 VS 2030
2.2 Global Nuclear Radiopharmaceutical Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Nuclear Radiopharmaceutical Sales: 2019-2030
3 Company Landscape
3.1 Top Nuclear Radiopharmaceutical Players in Global Market
3.2 Top Global Nuclear Radiopharmaceutical Companies Ranked by Revenue
3.3 Global Nuclear Radiopharmaceutical Revenue by Companies
3.4 Global Nuclear Radiopharmaceutical Sales by Companies
3.5 Global Nuclear Radiopharmaceutical Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Nuclear Radiopharmaceutical Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Nuclear Radiopharmaceutical Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Radiopharmaceutical Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Radiopharmaceutical Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Radiopharmaceutical Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nuclear Radiopharmaceutical Market Size Markets, 2023 & 2030
4.1.2 Diagnostic
4.1.3 Therapeutic
4.2 By Type - Global Nuclear Radiopharmaceutical Revenue & Forecasts
4.2.1 By Type - Global Nuclear Radiopharmaceutical Revenue, 2019-2024
4.2.2 By Type - Global Nuclear Radiopharmaceutical Revenue, 2025-2030
4.2.3 By Type - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
4.3 By Type - Global Nuclear Radiopharmaceutical Sales & Forecasts
4.3.1 By Type - Global Nuclear Radiopharmaceutical Sales, 2019-2024
4.3.2 By Type - Global Nuclear Radiopharmaceutical Sales, 2025-2030
4.3.3 By Type - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
4.4 By Type - Global Nuclear Radiopharmaceutical Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nuclear Radiopharmaceutical Market Size, 2023 & 2030
5.1.2 Oncology
5.1.3 Thyroid
5.1.4 Cardiology
5.1.5 Others
5.2 By Application - Global Nuclear Radiopharmaceutical Revenue & Forecasts
5.2.1 By Application - Global Nuclear Radiopharmaceutical Revenue, 2019-2024
5.2.2 By Application - Global Nuclear Radiopharmaceutical Revenue, 2025-2030
5.2.3 By Application - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
5.3 By Application - Global Nuclear Radiopharmaceutical Sales & Forecasts
5.3.1 By Application - Global Nuclear Radiopharmaceutical Sales, 2019-2024
5.3.2 By Application - Global Nuclear Radiopharmaceutical Sales, 2025-2030
5.3.3 By Application - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
5.4 By Application - Global Nuclear Radiopharmaceutical Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Nuclear Radiopharmaceutical Market Size, 2023 & 2030
6.2 By Region - Global Nuclear Radiopharmaceutical Revenue & Forecasts
6.2.1 By Region - Global Nuclear Radiopharmaceutical Revenue, 2019-2024
6.2.2 By Region - Global Nuclear Radiopharmaceutical Revenue, 2025-2030
6.2.3 By Region - Global Nuclear Radiopharmaceutical Revenue Market Share, 2019-2030
6.3 By Region - Global Nuclear Radiopharmaceutical Sales & Forecasts
6.3.1 By Region - Global Nuclear Radiopharmaceutical Sales, 2019-2024
6.3.2 By Region - Global Nuclear Radiopharmaceutical Sales, 2025-2030
6.3.3 By Region - Global Nuclear Radiopharmaceutical Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Nuclear Radiopharmaceutical Revenue, 2019-2030
6.4.2 By Country - North America Nuclear Radiopharmaceutical Sales, 2019-2030
6.4.3 US Nuclear Radiopharmaceutical Market Size, 2019-2030
6.4.4 Canada Nuclear Radiopharmaceutical Market Size, 2019-2030
6.4.5 Mexico Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Nuclear Radiopharmaceutical Revenue, 2019-2030
6.5.2 By Country - Europe Nuclear Radiopharmaceutical Sales, 2019-2030
6.5.3 Germany Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.4 France Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.5 U.K. Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.6 Italy Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.7 Russia Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.8 Nordic Countries Nuclear Radiopharmaceutical Market Size, 2019-2030
6.5.9 Benelux Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Nuclear Radiopharmaceutical Revenue, 2019-2030
6.6.2 By Region - Asia Nuclear Radiopharmaceutical Sales, 2019-2030
6.6.3 China Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6.4 Japan Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6.5 South Korea Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6.6 Southeast Asia Nuclear Radiopharmaceutical Market Size, 2019-2030
6.6.7 India Nuclear Radiopharmaceutical Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Nuclear Radiopharmaceutical Revenue, 2019-2030
6.7.2 By Country - South America Nuclear Radiopharmaceutical Sales, 2019-2030
6.7.3 Brazil Nuclear Radiopharmaceutical Market Size, 2019-2030
6.7.4 Argentina Nuclear Radiopharmaceutical Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nuclear Radiopharmaceutical Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Nuclear Radiopharmaceutical Sales, 2019-2030
6.8.3 Turkey Nuclear Radiopharmaceutical Market Size, 2019-2030
6.8.4 Israel Nuclear Radiopharmaceutical Market Size, 2019-2030
6.8.5 Saudi Arabia Nuclear Radiopharmaceutical Market Size, 2019-2030
6.8.6 UAE Nuclear Radiopharmaceutical Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Nihon Medi-Physics Co.,Ltd.
7.1.1 Nihon Medi-Physics Co.,Ltd. Company Summary
7.1.2 Nihon Medi-Physics Co.,Ltd. Business Overview
7.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Major Product Offerings
7.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.1.5 Nihon Medi-Physics Co.,Ltd. Key News & Latest Developments
7.2 Curium Pharma
7.2.1 Curium Pharma Company Summary
7.2.2 Curium Pharma Business Overview
7.2.3 Curium Pharma Nuclear Radiopharmaceutical Major Product Offerings
7.2.4 Curium Pharma Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.2.5 Curium Pharma Key News & Latest Developments
7.3 Cardinal Health
7.3.1 Cardinal Health Company Summary
7.3.2 Cardinal Health Business Overview
7.3.3 Cardinal Health Nuclear Radiopharmaceutical Major Product Offerings
7.3.4 Cardinal Health Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.3.5 Cardinal Health Key News & Latest Developments
7.4 Bayer Global
7.4.1 Bayer Global Company Summary
7.4.2 Bayer Global Business Overview
7.4.3 Bayer Global Nuclear Radiopharmaceutical Major Product Offerings
7.4.4 Bayer Global Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.4.5 Bayer Global Key News & Latest Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Company Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Nuclear Radiopharmaceutical Major Product Offerings
7.5.4 GE Healthcare Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.5.5 GE Healthcare Key News & Latest Developments
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Company Summary
7.6.2 Mallinckrodt Pharmaceuticals Business Overview
7.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Major Product Offerings
7.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.6.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.7 Bracco Group
7.7.1 Bracco Group Company Summary
7.7.2 Bracco Group Business Overview
7.7.3 Bracco Group Nuclear Radiopharmaceutical Major Product Offerings
7.7.4 Bracco Group Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.7.5 Bracco Group Key News & Latest Developments
7.8 Advanced Molecular-imaging Solution
7.8.1 Advanced Molecular-imaging Solution Company Summary
7.8.2 Advanced Molecular-imaging Solution Business Overview
7.8.3 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Major Product Offerings
7.8.4 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.8.5 Advanced Molecular-imaging Solution Key News & Latest Developments
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Company Summary
7.9.2 China Isotope & Radiation Business Overview
7.9.3 China Isotope & Radiation Nuclear Radiopharmaceutical Major Product Offerings
7.9.4 China Isotope & Radiation Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.9.5 China Isotope & Radiation Key News & Latest Developments
7.10 Ciaeriar
7.10.1 Ciaeriar Company Summary
7.10.2 Ciaeriar Business Overview
7.10.3 Ciaeriar Nuclear Radiopharmaceutical Major Product Offerings
7.10.4 Ciaeriar Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.10.5 Ciaeriar Key News & Latest Developments
7.11 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
7.11.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Summary
7.11.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Business Overview
7.11.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Major Product Offerings
7.11.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales and Revenue in Global (2019-2024)
7.11.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Key News & Latest Developments
8 Global Nuclear Radiopharmaceutical Production Capacity, Analysis
8.1 Global Nuclear Radiopharmaceutical Production Capacity, 2019-2030
8.2 Nuclear Radiopharmaceutical Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Radiopharmaceutical Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nuclear Radiopharmaceutical Supply Chain Analysis
10.1 Nuclear Radiopharmaceutical Industry Value Chain
10.2 Nuclear Radiopharmaceutical Upstream Market
10.3 Nuclear Radiopharmaceutical Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Radiopharmaceutical Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
